Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, ...

FDA Recall #D-0066-2021 — Class III — October 26, 2020

Recall #D-0066-2021 Date: October 26, 2020 Classification: Class III Status: Terminated

Product Description

Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by: Jubilant Generics, Ltd., Roorkee, India, Marketed by: Jubilant Cardista Pharmaceuticals, Inc., Salisbury, MD NDC 59746-0306-32

Reason for Recall

Subpotent

Recalling Firm

Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

23,616 blister packs

Distribution

Product was distributed nationwide

Code Information

Lot # AE119001A, exp. date 01/2021

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated